Tanmed Pharma India Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 07-12-2024
- Paid Up Capital ₹ 1.50 Cr
as on 07-12-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.75 Cr
as on 07-12-2024
- Revenue 10727813.61%
(FY 2023)
- Profit 10648367.63%
(FY 2023)
- Ebitda 10906218.08%
(FY 2023)
- Net Worth 11834308.49%
(FY 2023)
- Total Assets 10166922.33%
(FY 2023)
About Tanmed Pharma India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹1.75 Cr.
Chandra Rajan, Ketchaani Makesh, and Suresh Kumar serve as directors at the Company.
- CIN/LLPIN
U74999TN2015PTC100948
- Company No.
100948
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jun 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Tanmed Pharma India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ketchaani Makesh  | Director | 15-Jun-2015 | Current |
| Chandra Rajan | Director | 15-Jun-2015 | Current |
| Suresh Kumar | Director | 15-Jun-2015 | Current |
Financial Performance of Tanmed Pharma India.
Tanmed Pharma India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10727813.61% increase. The company also saw a substantial improvement in profitability, with a 10648367.63% increase in profit. The company's net worth Soared by an impressive increase of 11834308.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tanmed Pharma India?
Unlock access to Tanmed Pharma India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Biomiicron Pharma India Private LimitedActive 12 years 5 monthsKetchaani Makesh and Suresh Kumar are mutual person
Macsur Pharmaa (India) Private LimitedActive 18 years 6 monthsChandra Rajan and Ketchaani Makesh are mutual person
- Nattura Bio-Care Private LimitedActive 26 years 5 months
Ketchaani Makesh and Suresh Kumar are mutual person
- Biomaarks Drugs India Private LimitedActive 19 years 4 months
Ketchaani Makesh and Suresh Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 15 Sep 2015 | ₹1.75 Cr | Open |
How Many Employees Work at Tanmed Pharma India?
Tanmed Pharma India has a workforce of 71 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tanmed Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tanmed Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
